Authors:
Benet, LZ
Izumi, T
Zhang, YC
Silverman, JA
Wacher, VJ
Citation: Lz. Benet et al., Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery, J CONTR REL, 62(1-2), 1999, pp. 25-31
Citation: T. Mizuma et al., Interaction of human serum albumin with furosemide glucuronide: a role of albumin in isomerization, hydrolysis, reversible binding and irreversible binding of a 1-O-acyl glucuronide metabolite, BIOPHARM DR, 20(3), 1999, pp. 131-136
Authors:
Jacobsen, W
Kirchner, G
Hallensleben, K
Mancinelli, L
Deters, M
Hackbarth, I
Benet, LZ
Sewing, KF
Christians, U
Citation: W. Jacobsen et al., Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver, DRUG META D, 27(2), 1999, pp. 173-179
Authors:
Jager, W
Correia, MA
Bornheim, LM
Mahnke, A
Hanstein, WG
Xue, LL
Benet, LZ
Citation: W. Jager et al., Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: Implication for cyclosporine metabolism, DRUG META D, 27(12), 1999, pp. 1505-1511
Citation: L. Salphati et Lz. Benet, Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A, XENOBIOTICA, 29(2), 1999, pp. 171-185
Authors:
Hausen, B
Boeke, K
Berry, GJ
Segarra, I
Benet, LZ
Christians, U
Morris, RE
Citation: B. Hausen et al., Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to ratlung allograft recipients - Potentiation of immunosuppressive efficacy andimprovement of tolerability by staggered versus simultaneous treatment, TRANSPLANT, 67(7), 1999, pp. 956-962
Citation: Yc. Zhang et al., In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes, PHARMACOL, 58(3), 1999, pp. 147-159
Authors:
Jacobsen, W
Kirchner, G
Hallensleben, K
Mancinelli, L
Deters, M
Hackbarth, I
Baner, K
Benet, LZ
Sewing, KF
Christians, U
Citation: W. Jacobsen et al., Small intestinal metabolism of the 3-hydroxy-3-methylglutary-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin, J PHARM EXP, 291(1), 1999, pp. 131-139
Authors:
Serkova, N
Litt, L
James, TL
Sadee, W
Leibfritz, D
Benet, LZ
Christians, U
Citation: N. Serkova et al., Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy, J PHARM EXP, 289(2), 1999, pp. 800-806
Authors:
Segarra, I
Brazelton, TR
Guterman, N
Hausen, B
Jacobsen, W
Morris, RE
Benet, LZ
Christians, U
Citation: I. Segarra et al., Development of a high-performance liquid chromatographic electrospray massspectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin, J CHROMAT B, 720(1-2), 1998, pp. 179-187
Authors:
Tsunoda, SM
Harris, RZ
Mroczkowski, PJ
Benet, LZ
Citation: Sm. Tsunoda et al., Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women, J CLIN PHAR, 38(12), 1998, pp. 1137-1143